Rilmenidine improves hepatic steatosis through p38-dependent pathway to higher the expression of farnesoid X receptor

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 385, Issue 1, 2012, Pages 51-56

  Yang, Po Sheng ^a,e   Wu, Hung Tsung ^b   Chung, Hsien Hui ^b   Chen, Chun Ta ^c   Chi, Chin Wen ^a   Yeh, Ching Hua ^d   Cheng, Juei Tang ^b,c,d  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^c CHI MEI MEDICAL CENTER   (Taiwan)

^d CHANG JUNG CHRISTIAN UNIVERSITY   (Taiwan)

^e MACKAY MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Farnesoid X receptor; Hepatic steatosis; Imidazoline I 1 receptor; p38; Rilmenidine

Indexed keywords

CALCIUM ION; EFAROXAN; ETHYLENE GLYCOL 1,2 BIS(2 AMINOPHENYL) ETHER N,N,N',N' TETRAACETIC ACID; FARNESOID X RECEPTOR; IMIDAZOLINE I1 RECEPTOR; OLEIC ACID; RILMENIDINE; SYNAPTOPHYSIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL STRAIN HEPG2; CONTROLLED STUDY; FATTY LIVER; HUMAN; HUMAN CELL; LIPID DIET; LIPID STORAGE; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

ANIMALS; CALCIUM; CELL LINE, TUMOR; DIET, HIGH-FAT; EGTAZIC ACID; FATTY LIVER; HUMANS; IMIDAZOLINE RECEPTORS; LIPID METABOLISM; MALE; MAP KINASE SIGNALING SYSTEM; MICE; MICE, INBRED C57BL; OLEIC ACID; OXAZOLES; RECEPTORS, CYTOPLASMIC AND NUCLEAR;

EID: 84857030777     PISSN: 00281298     EISSN: 14321912     Source Type: Journal    
DOI: 10.1007/s00210-011-0691-1     Document Type: Article

References (36)

1. P Bousquet 2000 Identification and characterization of I1 imidazoline receptors: their role in blood pressure regulation Am J Hypertens 13 84S 88S 10921526 10.1016/S0895-7061(00)00223-5 1:CAS:528:DC%2BD3cXltlOgurk%3D (Pubitemid 30459892)
2. S Cipriani A Mencarelli G Palladino S Fiorucci 2010 FXR activation reverses insulin resistance and lipid abnormalities and protects against liver steatosis in Zucker (fa/fa) obese rats J Lipid Res 51 771 784 19783811 10.1194/jlr.M001602 1:CAS:528:DC%2BC3cXjslenurs%3D
3. T Claudel B Staels F Kuipers 2005 The farnesoid X receptor: a molecular link between bile acid and lipid and glucose metabolism Arterioscler Thromb Vasc Biol 25 2020 2030 16037564 10.1161/01.ATV.0000178994.21828.a7 1:CAS:528:DC%2BD2MXhtVCltrjM (Pubitemid 41416297)
4. L Edwards D Fishman P Horowitz N Bourbon M Kester P Ernsberger 2001 The I1-imidazoline receptor in PC12 pheochromocytoma cells activates protein kinases C, extracellular signal-regulated kinase (ERK) and c-jun N-terminal kinase (JNK) J Neurochem 79 931 940 11739604 10.1046/j.1471-4159.2001.00632.x 1:CAS:528:DC%2BD3MXptFOhsLg%3D (Pubitemid 33117071)
5. PA Edwards HR Kast AM Anisfeld 2002 BAREing it all: the adoption of LXR and FXR and their roles in lipid homeostasis J Lipid Res 43 2 12 11792716 1:CAS:528:DC%2BD38XhtFWmt7s%3D (Pubitemid 34117211)
6. MM El-Mas HM El-Gowelli AR Ghazal OF Harraz MM Mohy El-Din 2009 Facilitation of central imidazoline I(1)-site/extracellular signal-regulated kinase/p38 mitogen-activated protein kinase signalling mediates the hypotensive effect of ethanol in rats with acute renal failure Br J Pharmacol 158 1629 1640 19845670 10.1111/j.1476-5381.2009.00444.x 1:CAS:528:DC%2BD1MXhsFSkurjK
7. P Ernsberger ME Graves LM Graff N Zakieh P Nguyen LA Collins KL Westbrooks GG Johnson 1995 I1-imidazoline receptors. Definition, characterization, distribution, and transmembrane signaling Ann N Y Acad Sci 763 22 42 7677333 10.1111/j.1749-6632.1995.tb32388.x 1:CAS:528:DyaK2MXoslOmtrc%3D
8. P Ernsberger JE Friedman RJ Koletsky 1997 The I1-imidazoline receptor: from binding site to therapeutic target in cardiovascular disease J Hypertens Suppl 15 S9 23 9050981 1:CAS:528:DyaK2sXhvVeit7c%3D
9. D Festi A Colecchia T Sacco M Bondi E Roda G Marchesini 2004 Hepatic steatosis in obese patients: clinical aspects and prognostic significance Obes Rev 5 27 42 14969505 10.1111/j.1467-789X.2004.00126.x 1:STN:280: DC%2BD2c%2FnvF2juw%3D%3D (Pubitemid 38173592)
10. BM Forman E Goode J Chen AE Oro DJ Bradley T Perlmann DJ Noonan LT Burka T McMorris WW Lamph RM Evans C Weinberger 1995 Identification of a nuclear receptor that is activated by farnesol metabolites Cell 81 687 693 7774010 10.1016/0092-8674(95)90530-8 1:CAS:528:DyaK2MXmtFOitbk%3D
11. HR Kast CM Nguyen CJ Sinal SA Jones BA Laffitte K Reue FJ Gonzalez TM Willson PA Edwards 2001 Farnesoid X-activated receptor induces apolipoprotein C-II transcription: a molecular mechanism linking plasma triglyceride levels to bile acids Mol Endocrinol 15 1720 1728 11579204 10.1210/me.15.10.1720 1:CAS:528:DC%2BD3MXnt12isbw%3D (Pubitemid 32939302)
12. JR Lewis SR Mohanty 2010 Nonalcoholic fatty liver disease: a review and update Dig Dis Sci 55 560 578 20101463 10.1007/s10620-009-1081-0
13. TT Lu JJ Repa DJ Mangelsdorf 2001 Orphan nuclear receptors as eLiXiRs and FiXeRs of sterol metabolism J Biol Chem 276 37735 37738 11459853 1:CAS:528:DC%2BD3MXotFOrsbs%3D
14. TN Lui CW Tsao SY Huang CH Chang JT Cheng 2010 Activation of imidazoline I2B receptors is linked with AMP kinase pathway to increase glucose uptake in cultured C2C12 cells Neurosci Lett 474 144 147 20298750 10.1016/j.neulet.2010. 03.024 1:CAS:528:DC%2BC3cXksFGkt7c%3D
15. PR Maloney DJ Parks CD Haffner AM Fivush G Chandra KD Plunket KL Creech LB Moore JG Wilson MC Lewis SA Jones TM Willson 2000 Identification of a chemical tool for the orphan nuclear receptor FXR J Med Chem 43 2971 2974 10956205 10.1021/jm0002127 1:CAS:528:DC%2BD3cXltVSiur0%3D (Pubitemid 30626755)
16. BA Neuschwander-Tetri SH Caldwell 2003 Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference Hepatology 37 1202 1219 12717402 10.1053/jhep.2003.50193 (Pubitemid 36538699)
17. CS Niu HT Wu KC Cheng KC Lin CT Chen JT Cheng 2011 A novel mechanism for decreasing plasma lipid level from imidazoline I-1 receptor activation in high fat diet-fed mice Horm Metab Res 43 458 463 21484668 10.1055/s-0031-1275325 1:CAS:528:DC%2BC3MXpvFekurc%3D
18. MA Ozog JX Wilson SJ Dixon DF Cechetto 1998 Rilmenidine elevates cytosolic free calcium concentration in suspended cerebral astrocytes J Neurochem 71 1429 1435 9751174 10.1046/j.1471-4159.1998.71041429.x 1:CAS:528:DyaK1cXmt1Kisbw%3D (Pubitemid 28443013)
19. W Raasch U Schafer J Chun P Dominiak 2001 Biological significance of agmatine, an endogenous ligand at imidazoline binding sites Br J Pharmacol 133 755 780 11454649 10.1038/sj.bjp.0704153 1:CAS:528:DC%2BD3MXls1WmtL8%3D (Pubitemid 32751786)
20. JJ Repa DJ Mangelsdorf 2002 The liver X receptor gene team: potential new players in atherosclerosis Nat Med 8 1243 1248 12411951 10.1038/nm1102-1243 1:CAS:528:DC%2BD38XotlWmu70%3D (Pubitemid 35373555)
21. D Separovic M Kester P Ernsberger 1996 Coupling of I1-imidazoline receptors to diacylglyceride accumulation in PC12 rat pheochromocytoma cells Mol Pharmacol 49 668 675 8609895 1:CAS:528:DyaK28XisVSksL8%3D (Pubitemid 26117151)
22. D Separovic M Kester MA Haxhiu P Ernsberger 1997 Activation of phosphatidylcholine-selective phospholipase C by I1-imidazoline receptors in PC12 cells and rostral ventrolateral medulla Brain Res 749 335 339 9138734 10.1016/S0006-8993(96)01372-8 1:CAS:528:DyaK2sXpt12gug%3D%3D (Pubitemid 27104215)
23. CJ Sinal M Tohkin M Miyata JM Ward G Lambert FJ Gonzalez 2000 Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis Cell 102 731 744 11030617 10.1016/S0092-8674(00)00062-3 1:CAS:528:DC%2BD3cXmvFShtr8%3D
24. C Soderberg P Stal J Askling H Glaumann G Lindberg J Marmur R Hultcrantz 2010 Decreased survival of subjects with elevated liver function tests during a 28-year follow-up Hepatology 51 595 602 20014114 10.1002/hep.23314
25. Sun C, Wang L, Yan J, Liu S (2011) Calcium ameliorates obesity induced by high-fat diet and its potential correlation with p38 MAPK pathway. Mol Biol Rep. doi: 10.1007/s11033-011-0916-x
26. LS Szczepaniak RG Victor L Orci RH Unger 2007 Forgotten but not gone: the rediscovery of fatty heart, the most common unrecognized disease in America Circ Res 101 759 767 17932333 10.1161/CIRCRESAHA.107.160457 1:CAS:528: DC%2BD2sXhtFejsL7L (Pubitemid 350287190)
27. G Targher L Bertolini F Poli S Rodella L Scala R Tessari L Zenari G Falezza 2005 Nonalcoholic fatty liver disease and risk of future cardiovascular events among type 2 diabetic patients Diabetes 54 3541 3546 16306373 10.2337/diabetes.54.12.3541 1:CAS:528:DC%2BD2MXht12gsL%2FN (Pubitemid 43334347)
28. DG Tiniakos MB Vos EM Brunt 2010 Nonalcoholic fatty liver disease: pathology and pathogenesis Annu Rev Pathol 5 145 171 20078219 10.1146/annurev-pathol-121808-102132 1:CAS:528:DC%2BC3cXivFekt7s%3D
29. RA Velliquette R Kossover SF Previs P Ernsberger 2006 Lipid-lowering actions of imidazoline antihypertensive agents in metabolic syndrome X Naunyn Schmiedebergs Arch Pharmacol 372 300 312 16416266 10.1007/s00210-005-0024-3 1:CAS:528:DC%2BD28XltVSjtg%3D%3D (Pubitemid 43119564)
30. SR Wang M Pessah J Infante D Catala C Salvat R Infante 1988 Lipid and lipoprotein metabolism in Hep G2 cells Biochim Biophys Acta 961 351 363 3042028 1:CAS:528:DyaL1cXltVyjtbc%3D
31. M Watanabe SM Houten L Wang A Moschetta DJ Mangelsdorf RA Heyman DD Moore J Auwerx 2004 Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c J Clin Invest 113 1408 1418 15146238 1:CAS:528: DC%2BD2cXktlCltro%3D (Pubitemid 39071696)
32. A Wieckowska AJ McCullough AE Feldstein 2007 Noninvasive diagnosis and monitoring of nonalcoholic steatohepatitis: present and future Hepatology 46 582 589 17661414 10.1002/hep.21768 1:CAS:528:DC%2BD2sXhtVSisbzE (Pubitemid 47344794)
33. 2+-evoked p38 signaling pathway Naunyn Schmiedebergs Arch Pharmacol 383 321 330 21279332 10.1007/s00210-011-0598-x 1:CAS:528:DC%2BC3MXitFKjsb8%3D
34. Y Zhang HR Kast-Woelbern PA Edwards 2003 Natural structural variants of the nuclear receptor farnesoid X receptor affect transcriptional activation J Biol Chem 278 104 110 12393883 10.1074/jbc.M209505200 1:CAS:528: DC%2BD38XpvVWgsbc%3D (Pubitemid 36043550)
35. Y Zhang LW Castellani CJ Sinal FJ Gonzalez PA Edwards 2004 Peroxisome proliferator-activated receptor-gamma coactivator 1alpha (PGC-1alpha) regulates triglyceride metabolism by activation of the nuclear receptor FXR Genes Dev 18 157 169 14729567 10.1101/gad.1138104 1:CAS:528:DC%2BD2cXhtFSkurs%3D (Pubitemid 38141784)
36. D Zhang J Christianson ZX Liu L Tian CS Choi S Neschen J Dong PA Wood GI Shulman 2010 Resistance to high-fat diet-induced obesity and insulin resistance in mice with very long-chain acyl-CoA dehydrogenase deficiency Cell Metab 11 402 411 20444420 10.1016/j.cmet.2010.03.012 1:CAS:528:DC%2BC3cXmtleis7c%3D